September 2018

The National Institute of Immunology (NII) is committed to advanced research addressing the basic mechanisms involved in body's defence to identify modalities for manipulation of the immune system to provide protection against diseases and understand mechanisms that can be used to target disease processes for intervention. The institute’s research thrust areas under immunology and related disciplines cluster in four main themes, namely, infection and immunity, molecular design, gene regulation and reproduction and development, where cutting edge research in modern biology is being carried out.

Applications are invited for the position of Research Associate / Senior Research Fellow/Junior Research Fellow (Project) for the following time bound sponsored project.

1mg is India’s leading consumer health platform with over 3 Million downloads. It aspires to be the trusted health partner for all Indians and its mission is to make healthcare accessible, understandable and affordable for a billion Indians. It enables consumers to learn more about their medicines and also find more cost-effective substitutes. 1mg’s doctor platform aims to revolutionize how a consumer finds the right healthcare professional for his needs. It’s recently launched diagnostics service brings transparency and price-effectiveness to lab tests. 1mg is an initiative taken in the spirit of public service with a vision to empower Indian consumers and caregivers to select the most appropriate healthcare service at the best possible price.

Post: Pharmacist

Apotex is a proudly Canadian, global pharmaceutical company that produces high-quality, affordable medicines (both generic and innovative pharmaceuticals) for patients around the world. We are the 7th largest generic pharmaceutical company globally with more than 12,000 employees and estimated sales of approximately $3 billion. Our fully integrated operation is comprised of four lines of business: Global Generics; Apobiologix; Global Active Pharmaceutical Ingredients (API); and ApoPharma (Innovative Products). With our worldwide manufacturing sites, Apotex can produce up to 24 billion dosages per year. We produce 300 medicines in 4,000 dosages and formats that are exported to 115 countries. Apotex will spend $2 billion over the next 10 years on research and development.

Post : Associate / Sr. Associate - Global Pharmacovigilance

Roche Pharmaceuticals, India, has been disseminating scientific knowledge pertaining to innovative medicines to the medical fraternity. We have products in therapeutic areas such as Oncology, Virology, Nephrology, Transplantation, Anemia and Rheumatoid Arthritis. In recognition of its contributions in Oncology, Roche India has been awarded the Best Oncology Company of the Year, by Frost & Sullivan at the India Healthcare Excellence Awards for the years 2011, 2012 and 2014.

Post : Value Specialist

ABOUT AUTHOR
DR. PRANJAL BORDOLOI
VP – PHARMACOLGY & COD
VEEDA CLINICAL RESEARCH PVT LTD.
info@veedacr.com

Therapeutic innovation in cancer treatment has always been in focus. Based on WHO data, worldwide, there were 14.1 million new cancer cases, 8.2 million cancer deaths, and 32.6 million people living with cancer within 5 years of diagnosis by year 2012. Top 5 most frequent cancers in world (ranked by number of new cases) are breast, prostate, lung, colorectal, and cervical cancers per 2012 WHO data (International Agency for Research on Cancer, WHO). For countries like India, the top 5 most frequent cancers (ranked by number of new cases) are breast, cervical, oral cavity, lung and colorectal cancers (International Agency for Research on Cancer, WHO). Reported age-adjusted incidence rates for cancer are still quite low in the demographically young country. Little more than 1 million new cases of cancer are diagnosed every year in India. An estimated 600 000–700 000 deaths in India were caused by cancer in 2012. In age-standardized terms this is close to the mortality burden seen in high-income countries. Such figures are somewhat indicative of low rates of early-stage detection and poor treatment outcomes (Mallath MK, et al. 2014).

Indian Pharmaceutical Association (IPA) in association with ACG Worldwide (ACG) & SciTech Centre (SciTech) are pleased to announce the 5th IPA ACG - SciTech Innovation Awards for the best innovations in the development of Solid Dosage Forms and packaging of pharmaceuticals of the year.

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
S.Sarojini¹, B.Mounika,^2
1Department of Pharmaceutics, Shri Venkateshwara College of Pharmacy, Ariyur, Puducherry, India
²Department of Pharmaceutics, Nalanda College of Pharmacy, Nalgonda, Telangana, India

ABSTRACT
Muntingia, or JamaicaCherry, is a small, fast growing tree that can reach up to 40 ft. tall at full maturity. The soft leaves are evergreen and have an alternate phyllotaxy. Leaves are dark green on top and light green underneath. The small, white flowers feature yellow stamens in the center. The small, round fruits are abundant, and depending on the variety, have a red or yellow color. Fruits are edible raw or made into jam. The fruit possessed potent anti-inflammatory activity. The flowers have antiseptic and antispasmodic qualities, and are made into medicinal teas. The M. calabura leaves exhibited potential anti-proliferative and antioxidant activities. The present study on Muntingia is to give an overview on traditional uses and pharmacological activity.

PERD Bio-incubator invites applications from students / young faculty members /  research scholars and other interested people in pharma, Biotech, life science, health care and allied science sector who wishes to start a new business based on innovative ideas & are having solutions to the existing problems in society. The interested applicant can be at
1. Ideation stage
2. Proof of concept stage
3. Scaling up stage
4. Marketing and business development stage

PERD Bio-incubator provides hand-holding at all stages of entrepreneurial development and also helps for getting funds from various Govt. schemes and investors.

Objectives

• To support innovators to become entrepreneur
• To provide easy entry and exit from the in the scheme
• To provide networking support to startups
• To provide a research ambience and expert services
• To support innovators and startups with skilled human resources

For more details about the incubator and for the application format please visit : http://perdcentre.com/BIRAC.html
or contact us on email at : perd@perdcentre.com, neetas@perdcentre.com
or on phone at : +917927439375

Applications are invited from the eligible candidates of District Pulwama for below posts, as per the criteria shown against each.